His primary scientific interests are in Immunology, Immune system, Allergy, Interleukin 4 and Antigen. Much of his study explores Immunology relationship to Cytotoxic T cell. The concepts of his Allergy study are interwoven with issues in Atopic dermatitis, Guideline, Physical therapy and Intensive care medicine.
Many of his research projects under Interleukin 4 are closely connected to Leishmania major with Leishmania major, tying the diverse disciplines of science together. The study incorporates disciplines such as Allergen and Disease in addition to Anaphylaxis. In his study, Internal medicine is inextricably linked to Peanut allergy, which falls within the broad field of Disease.
His primary areas of investigation include Immunology, Dermatology, Allergy, Immune system and Anaphylaxis. Immunoglobulin E, Allergen, Inflammation, Sensitization and Atopic dermatitis are the subjects of his Immunology studies. His research in Immunoglobulin E is mostly concerned with Basophil activation.
His research on Allergy focuses in particular on Food allergy. His study in Innate immune system and T cell are all subfields of Immune system. His works in TLR2 and Toll-like receptor are all subjects of inquiry into Innate immune system.
His main research concerns Coronavirus disease 2019, Dermatology, Severe acute respiratory syndrome coronavirus 2, 2019-20 coronavirus outbreak and Immunology. His Dermatology study combines topics in areas such as Ambulatory care and Ulcerative colitis. Tilo Biedermann has included themes like Gynecology, MEDLINE, Anaphylaxis and Vaccination in his 2019-20 coronavirus outbreak study.
His work is connected to Allergy, Immunoglobulin E, Immune system and Inflammation, as a part of Immunology. His studies deal with areas such as Antibody, Basophil activation, Alder and Intensive care medicine as well as Allergy. The Immune system study combines topics in areas such as CEBPB, Precision medicine, Omics and Genetic predisposition.
Tilo Biedermann spends much of his time researching Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Immunology, 2019-20 coronavirus outbreak and Anaphylaxis. His work in the fields of Immunology, such as Inflammation, Immune system, Immunotherapy and Immunoglobulin E, overlaps with other areas such as Homologous chromosome. His biological study spans a wide range of topics, including Innate immune system, CCL5 and Cytokine.
His work on Immunity as part of general Immune system study is frequently linked to Context, bridging the gap between disciplines. His 2019-20 coronavirus outbreak study incorporates themes from Melanoma patient, Cancer research, Gynecology and Immune checkpoint inhibitors. Tilo Biedermann focuses mostly in the field of Anaphylaxis, narrowing it down to matters related to Intensive care medicine and, in some cases, Guideline and Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy.
Nature Medicine (2012)
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Kamran Ghoreschi;Peter Thomas;Susanne Breit;Martin Dugas.
Nature Medicine (2003)
Mast Cells Control Neutrophil Recruitment during T Cell–Mediated Delayed-Type Hypersensitivity Reactions through Tumor Necrosis Factor and Macrophage Inflammatory Protein 2
Tilo Biedermann;Manfred Kneilling;Reinhard Mailhammer;Konrad Maier.
Journal of Experimental Medicine (2000)
EAACI Molecular Allergology User's Guide.
P.M Matricardi;J Kleine-Tebbe;H.J Hoffmann;R Valenta.
Applied Immunohistochemistry & Molecular Morphology (2016)
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Tilo Biedermann;Tilo Biedermann;Stephan Zimmermann;Stephan Zimmermann;Hayo Himmelrich;Alain Gumy.
Nature Immunology (2001)
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis
Thomas Werfel;Jean-Pierre Allam;Tilo Biedermann;Kilian Eyerich.
The Journal of Allergy and Clinical Immunology (2016)
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Marcus Maurer;Sabine Altrichter;Thomas Bieber;Tilo Biedermann.
The Journal of Allergy and Clinical Immunology (2011)
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
Günther Weindl;Julian R. Naglik;Susanne Kaesler;Tilo Biedermann.
Journal of Clinical Investigation (2007)
HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation
Ute Feger;Eva Tolosa;Yu-Hwa Huang;Anne Waschbisch.
Fungal Chitin Dampens Inflammation through IL-10 Induction Mediated by NOD2 and TLR9 Activation
Jeanette Wagener;R. K.Subbarao Malireddi;Megan D. Lenardon;Martin Köberle.
PLOS Pathogens (2014)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: